Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A13630 | Pages: 261 | Charts: 49 | Tables: 128 |
The global hematology analyzer market size was valued at $1,962.40 million in 2020 and is projected to reach $3,941.10 million by 2030 registering a CAGR of 7.30% from 2021 to 2030. Hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample. They include programmable automated alarm systems for indicating results outside the reference range. Hematology analyzers are concerned with detection, monitoring of diseases, prognosis and subsequent screening and are extensively used against various blood related diseases such as hemophilia, blood cancer and blood clots. Other diseases include leukemia, anemia, blood transfusion, malignant lymphomas, and others where hematology diagnosis is used.
[COVIDIMPACTSTATEMENT]
Rise in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, is a major factor that drives the growth of the market. In addition, technological advancements in hematology analyzers, and growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer further fuel the growth of the hematology analyzer market. However, high cost of hematology analyzers owing to advanced features and automation may hinder the growth of the market. Furthermore, stringent regulatory policies for hematology analyzers are also expected to limit the growth of the market. In contrast, growth opportunities in emerging economics expected to offer lucrative opportunities for players in the hematology analyzer market.
Get more information on this report : Request Sample Pages
The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. However, there is positive effect on the hematology analyzer market owing to increase in focus on the hematology parameters for the assessment of COVID-19 around the world. Several studies are carried out in research institutions, and many of the hospitals started using the hematology analyzers to test and monitor COVID-19 patients without spreading the virus. For the practical and efficient screening of the large populations for the COVID-19 infection, some research studies from China recommended including white blood cells (WBC) and C-reactive protein (CRP) in laboratory examinations for early monitoring of infection. On March 18, 2020, Sight announced that Israel’s government-run Sheba Tel Hashomer Hospital is using its OLO, the first blood count device for point-of-care to conduct CBC tests to monitor and treat its COVID-19 patients to mitigate the risk of contamination.
The global hematology analyzer market is segmented on the basis of product & service, type, end user, and region to provide a detailed assessment of the market. By product & service, it is classified into instruments, reagent & consumables, and services. By type, it is segmented into fully-automated hematology analyzer and semi-automated hematology analyzer. Based on end user, it is categorized into hospitals, clinical laboratories, research institutes, and others. Other segment includes blood banks, and biopharma companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Based on product & service, the hematology analyzer market is segmented into instruments, reagent & consumables, and services. Reagent & consumables segment dominated the global market in 2020 and is expected to remain dominant throughout the forecast period owing to factors such as increase in adoption of reagent and consumables in clinical laboratories for blood cell counts, coagulation testing, other hematology tests, control, and calibration.
[PRODUCT&SERVICESGRAPH]
Get more information on this report : Request Sample Pages
Based on type, it is segmented into fully-automated hematology analyzer and semi-automated hematology analyzer. Fully-automated hematology analyzer segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. This is attributed to growing preference for automated hematology instruments, along with increasing technological advancements, and the combination of basic flow-cytometry techniques in automated hematology analyzers.
Based on end user, it is classified into hospitals, clinical laboratories, research institutes, and others. Other segment includes blood banks, and biopharma companies. Clinical laboratories segment held the largest share in 2020 and is expected to remain dominant throughout the forecast period owing to presence of high-quality equipment in clinical laboratories and the accurate results obtained from them. Furthermore, convenience and accurate results in clinical laboratories are the two major reasons driving the growth of the segment during the forecast period.
[TYPEGRAPH]
Get more information on this report : Request Sample Pages
Asia-Pacific offers profitable opportunities for key players operating in the hematology analyzer market, thereby registering the fastest growth rate during the forecast period, owing to growing healthcare infrastructure, increasing prevalence of blood diseases, rising disposable incomes, well-established presence of domestic companies, and aging population in the region. In addition, factors such as increase in population and growth in the economies of developing countries such as India and China, are also supporting the growth of the hematology analyzer market in Asia. Technological advancements coupled with supportive investments and funds by the government, especially in developing countries, such as India and China, are also expected to contribute to market growth.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
The key market players profiled in the report include Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), Bio-Rad Laboratories, Boule Diagnostics AB, F Hoffmann-La Roche Ltd, Hobira Ltd, Nihon Kohden Corporation, Siemens Healthineers, Stratec SE (Diatron MI Plc.), and Sysmex Corporation.
Key Benefits For Stakeholders
Key Market Segments
By Product & Service
By Type
By End User
By Region
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of blood disorders
3.5.1.2.Technological advancements in hematology analyzers
3.5.1.3.Growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer
3.5.2.Restraints
3.5.2.1.High cost of hematology analyzers
3.5.2.2.Stringent regulatory policies for hematology analyzers
3.5.3.Opportunities
3.5.3.1.Growth opportunities in emerging economics
3.5.4.Impact analysis
3.6.COVID-19 Impact analysis on the hematology analyzer market
CHAPTER 4:HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICE
4.1.Overview
4.1.1.Market size and forecast
4.2.Instruments
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.2.1.Market size and forecast for instruments, by end user
4.2.3.Market analysis, by country
4.3.Reagents and consumables
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.2.1.Market size and forecast for reagents & consumables, by end user
4.3.3.Market analysis, by country
4.4.Services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.2.1.Market size and forecast for services, by end user
4.4.3.Market analysis, by country
CHAPTER 5:HEMATOLOGY ANALYZER MARKET, BY TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Fully Automated Hematology Analyzer
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Semi-Automated Hematology Analyzer
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:HEMATOLOGY ANALYZER MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Clinical Laboratories
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Research Institutes
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
6.5.Others
6.5.1.Market size and forecast
6.5.2.Market analysis, by country
CHAPTER 7:HEMATOLOGY ANALYZER MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. hematology analyzer market, by product & services
7.2.2.1.2.U.S. hematology analyzer market, by type
7.2.2.1.3.U.S. hematology analyzer market, by end user
7.2.2.2.Canada
7.2.2.2.1.Canada hematology analyzer market, by product & services
7.2.2.2.2.Canada hematology analyzer market, by type
7.2.2.2.3.Canada hematology analyzer market, by end user
7.2.2.3.Mexico
7.2.2.3.1.Mexico hematology analyzer market, by product & services
7.2.2.3.2.Mexico hematology analyzer market, by type
7.2.2.3.3.Mexico hematology analyzer market, by end user
7.2.3.North America market size and forecast, by product & services
7.2.4.North America market size and forecast, by type
7.2.5.North America market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany hematology analyzer market, by product & services
7.3.2.1.2.Germany hematology analyzer market, by type
7.3.2.1.3.Germany hematology analyzer market, by end user
7.3.2.2.France
7.3.2.2.1.France hematology analyzer market, by product & services
7.3.2.2.2.France hematology analyzer market, by type
7.3.2.2.3.France hematology analyzer market, by end user
7.3.2.3.UK
7.3.2.3.1.UK hematology analyzer market, by product & services
7.3.2.3.2.UK hematology analyzer market, by type
7.3.2.3.3.UK hematology analyzer market, by end user
7.3.2.4.Italy
7.3.2.4.1.Italy hematology analyzer market, by product & services
7.3.2.4.2.Italy hematology analyzer market, by type
7.3.2.4.3.Italy hematology analyzer market, by end user
7.3.2.5.Spain
7.3.2.5.1.Spain hematology analyzer market, by product & services
7.3.2.5.2.Spain hematology analyzer market, by type
7.3.2.5.3.Spain hematology analyzer market, by end user
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe hematology analyzer market, by product & services
7.3.2.6.2.Rest of Europe hematology analyzer market, by type
7.3.2.6.3.Rest of Europe hematology analyzer market, by end user
7.3.3.Europe market size and forecast, by product & services
7.3.4.Europe market size and forecast, by type
7.3.5.Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan hematology analyzer market, by product & services
7.4.2.1.2.Japan hematology analyzer market, by type
7.4.2.1.3.Japan hematology analyzer market, by end user
7.4.2.2.China
7.4.2.2.1.China hematology analyzer market, by product & services
7.4.2.2.2.China hematology analyzer market, by type
7.4.2.2.3.China hematology analyzer market, by end user
7.4.2.3.Australia
7.4.2.3.1.Australia hematology analyzer market, by product & services
7.4.2.3.2.Australia hematology analyzer market, by type
7.4.2.3.3.Australia hematology analyzer market, by end user
7.4.2.4.India
7.4.2.4.1.India hematology analyzer market, by product & services
7.4.2.4.2.India hematology analyzer market, by type
7.4.2.4.3.India hematology analyzer market, by end user
7.4.2.5.South Korea
7.4.2.5.1.South Korea hematology analyzer market, by Product & services
7.4.2.5.2.South Korea hematology analyzer market, by type
7.4.2.5.3.South Korea hematology analyzer market, by end user
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific hematology analyzer market, by product & services
7.4.2.6.2.Rest of Asia-Pacific hematology analyzer market, by type
7.4.2.6.3.Rest of Asia-Pacific hematology analyzer market, by end user
7.4.3.Asia-Pacific market size and forecast, by product & services
7.4.4.Asia-Pacific market size and forecast, by type
7.4.5.Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil hematology analyzer market, by product & services
7.5.2.1.2.Brazil hematology analyzer market, by type
7.5.2.1.3.Brazil hematology analyzer market, by end user
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia hematology analyzer market, by product & services
7.5.2.2.2.Saudi Arabia hematology analyzer market, by type
7.5.2.2.3.Saudi Arabia hematology analyzer market, by end user
7.5.2.3.South Africa
7.5.2.3.1.South Africa hematology analyzer market, by product & services
7.5.2.3.2.South Africa hematology analyzer market, by type
7.5.2.3.3.South Africa hematology analyzer market, by end user
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA hematology analyzer market, by product & services
7.5.2.4.2.Rest of LAMEA hematology analyzer market, by type
7.5.2.4.3.Rest of LAMEA hematology analyzer market, by end user
7.5.3.LAMEA market size and forecast, by product & services
7.5.4.LAMEA market size and forecast, by type
7.5.5.LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.BIO-RAD LABORATORIES, INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.BOULE DIAGNOSTICS AB
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.DANAHER CORPORATION (BECKMAN COULTER INC.)
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.F. HOFFMANN-LA ROCHE AG
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.HORIBA, LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.NIHON KOHDEN CORPORATION
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.SIEMENS AG
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.STRATEC SE (DIATRON MI PLC)
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.SYSMEX CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 02.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY REGION, 2020-2030($MILLION)
TABLE 03.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY END USER, 2020-2030($MILLION)
TABLE 04.HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020-2030($MILLION)
TABLE 05.HEMATOLOGY ANALYZER MARKET FOR REAGENTS & CONSUMABLES, BY END USER, 2020-2030($MILLION)
TABLE 06.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY REGION, 2020-2030($MILLION)
TABLE 07.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY END USER, 2020-2030($MILLION)
TABLE 08.GLOBAL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 09.HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 10.HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 11.GLOBAL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 12.HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY REGION, 2020-2030($MILLION)
TABLE 13.HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2030($MILLION)
TABLE 14.HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020-2030($MILLION)
TABLE 15.HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY REGION, 2020-2030($MILLION)
TABLE 16.HEMATOLOGY ANALYZER MARKET, BY REGION, 2020-2030($MILLION)
TABLE 17.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 18.U.S. HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 19.U.S. HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 20.U.S. HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 21.CANADA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 22.CANADA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 23.CANADA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 24.MEXICO HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 25.MEXICO HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 26.MEXICO HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 27.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 28.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 29.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30.EUROPE HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 31.GERMANY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 32.GERMANY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 33.GERMANY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 34.FRANCE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 35.FRANCE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 36.FRANCE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 37.UK HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 38.UK HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 39.UK HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 40.ITALY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 41.ITALY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 42.ITALY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43.SPAIN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 44.SPAIN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 45.SPAIN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 47.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 48.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 49.EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 50.EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 51.EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 53.JAPAN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 54.JAPAN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 55.JAPAN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 56.CHINA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 57.CHINA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 58.CHINA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 59.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 60.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 61.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 62.INDIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 63.INDIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 64.INDIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 66.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 67.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 68.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 69.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 70.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 72.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 73.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74.LAMEA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 75.BRAZIL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 76.BRAZIL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 77.BRAZIL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 78.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 79.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 80.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 81.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 82.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 83.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY END USER 2020-2030($MILLION)
TABLE 84.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 85.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 86.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, END USER, 2020-2030($MILLION)
TABLE 87.LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 88.LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 89.LAMEA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 90.ABBOTT: COMPANY SNAPSHOT
TABLE 91.ABBOTT: OPERATING SEGMENTS
TABLE 92.ABBOTT: PRODUCT PORTFOLIO
TABLE 93.ABBOTT: KEY DEVELOPMENTS
TABLE 94.BIORAD: COMPANY SNAPSHOT
TABLE 95.BIORAD: OPERATING SEGMENTS
TABLE 96.BIORAD: PRODUCT PORTFOLIO
TABLE 97.BOULE: COMPANY SNAPSHOT
TABLE 98.BOULE: OPERATING SEGMENTS
TABLE 99.BOULE: PRODUCT PORTFOLIO
TABLE 100.BOULE: KEY DEVELOPMENTS
TABLE 101.DANAHER: COMPANY SNAPSHOT
TABLE 102.DANAHER: OPERATING SEGMENTS
TABLE 103.DANAHER: PRODUCT PORTFOLIO
TABLE 104.DANAHER: KEY DEVELOPMENTS
TABLE 105.ROCHE: COMPANY SNAPSHOT
TABLE 106.ROCHE: OPEARING SEGMENTS
TABLE 107.ROCHE: PRODUCT PORTFOLIO
TABLE 108.ROCHE: KEY DEVELOPMENTS
TABLE 109.HORIBA: COMPANY SNAPSHOT
TABLE 110.HORIBA: OPERATING SEGMENTS
TABLE 111.HORIBA: PRODUCT PORTFOLIO
TABLE 112.HORIBA: KEY DEVELOPMENTS
TABLE 113.NIHON: COMPANY SNAPSHOT
TABLE 114.NIHON: OPERATING SEGMENTS
TABLE 115.NIHON: PRODUCT PORTFOLIO
TABLE 116.NIHON: KEY DEVELOPMENTS
TABLE 117.SIEMENS: COMPANY SNAPSHOT
TABLE 118.SIEMENS: OPERATING SEGMENTS
TABLE 119.SIEMENS: PRODUCT PORTFOLIO
TABLE 120.SIEMENS: KEY DEVELOPMENTS
TABLE 121.STRATEC: COMPANY SNAPSHOT
TABLE 122.STRATEC: OPERATING SEGMENTS
TABLE 123.STRATEC: PRODUCT PORTFOLIO
TABLE 124.STRATEC: KEY DEVELOPMENTS
TABLE 125.SYSMEX: COMPANY SNAPSHOT
TABLE 126.SYSMEX: OPERATING SEGMENTS
TABLE 127.SYSMEX: PRODUCT PORTFOLIO
TABLE 128.SIEMENS: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.HEMATOLOGY ANALYZER MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.ABBOTT: REVENUE SHARE BY REGION, 2020(%)
FIGURE 25.BIORAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.BIORAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.BIORAD: REVENUE SHARE BY REGION, 2020(%)
FIGURE 28.BOULE: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 32.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.ROCHE: REVENUE SHARE BY REGION, 2020(%)
FIGURE 35.HORIBA: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.HORIBA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.HORIBA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.NIHON: NET SALES, 2019–2021 ($MILLION)
FIGURE 39.NIHON: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 40.NIHON: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 41.SIEMENS: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.SIEMENS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 44.STRATEC: NET SALES, 2018–2020 ($MILLION)
FIGURE 45.STRATEC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46.STRATEC: REVENUE SHARE BY REGION, 2020(%)
FIGURE 47.SYSMEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 48.SYSMEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49.SYSMEX: REVENUE SHARE BY REGION, 2020(%)